Humana (HUM) Cash from Investing Activities (2009 - 2026)

Humana (HUM) has reported Cash from Investing Activities for 18 consecutive years, with -$273.0 million the latest figure, recorded in Q2 2026.

• In Q2 2026, Cash from Investing Activities fell 178.67% year-over-year to -$273.0 million; the TTM figure through Jun 2026 stood at -$1.2 billion (down 38.74% YoY), while the FY2025 annual figure was $2.3 billion, up 177.0% from the prior year.
• Cash from Investing Activities improved to -$273.0 million in Q2 2026 per HUM's latest filing, from -$2.6 billion in the prior quarter.
• Across five years, Cash from Investing Activities topped out at $1.7 billion in Q3 2022 and bottomed at -$2.6 billion in Q1 2026.
• Historically, Cash from Investing Activities has averaged -$444.6 million across 5 years, with a median of -$616.5 million in 2022.
• Annual changes were most pronounced in 2025 — Cash from Investing Activities jumped 1103.17% — and 2026, when it sank 913.06%.
• Humana's Cash from Investing Activities stood at -$1.0 billion in 2022, then rose by 12.85% to -$882.0 million in 2023, then surged by 92.86% to -$63.0 million in 2024, then surged by 1103.17% to $632.0 million in 2025, then sank by 143.2% to -$273.0 million in 2026.
• Business Quant data shows HUM's Cash from Investing Activities at -$273.0 million in Q2 2026, -$2.6 billion in Q1 2026, and $632.0 million in Q4 2025.